跳到正文
Yüksel Ürün· @DrYukselUrun · X·· 23 小时前评分90

VOLGA

正文 · 原文

VOLGA: OS benefit without adjuvant EV.

Do we really need EV after surgery? An important question for future trials.

Proud to have contributed to this study.

@myESMO @OncoAlert @OpenMedicineHQ #ESMO26 @tompowles1 @Uromigos @urologysummit

357 浏览 · 12 赞 · 6 转发 · 0 回复

会议摘要
LBA2按 Presidential Symposium I 对上

Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial

https://esmocongress.esmo.org

来源:Yüksel Ürün · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org